MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors-Reference-Cited by-同舟云学术

MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors

Published:2012-12-10 Issue:1 Volume:123 Page:340-347
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Jessen Walter J.,Miller Shyra J.,Jousma Edwin,Wu Jianqiang,Rizvi Tilat A.,Brundage Meghan E.,Eaves David,Widemann Brigitte,Kim Mi-Ok,Dombi Eva,Sabo Jessica,Hardiman Dudley Atira,Niwa-Kawakita Michiko,Page Grier P.,Giovannini Marco,Aronow Bruce J.,Cripe Timothy P.,Ratner Nancy

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference63 articles.

1. Pubic Osteomyelitis due to Anaerobic Bacteria

2. Somatic loss of wild typeNF1 allele in neurofibromas: Comparison ofNF1 microdeletion and non-microdeletion patients

3. Pediatric Malignant Peripheral Nerve Sheath Tumor: The Italian and German Soft Tissue Sarcoma Cooperative Group

4. Malignant peripheral nerve sheath tumours in neurofibromatosis 1

Cited by 279 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ex Vivo Patient-Derived Explant Model for Neurofibromatosis Type 1–Related Cutaneous Neurofibromas;Journal of Investigative Dermatology;2024-09

2. Unraveling neuronal and metabolic alterations in neurofibromatosis type 1;Journal of Neurodevelopmental Disorders;2024-08-31

3. Efficacy of Trametinib in Neurofibromatosis Type 1–Associated Gastrointestinal Stromal Tumors: A Case Report;JCO Precision Oncology;2024-08

4. snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response;Acta Neuropathologica Communications;2024-06-21

5. An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies;Investigative Ophthalmology & Visual Science;2024-06-05